We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,946.00
Bid: 10,952.00
Ask: 10,954.00
Change: 32.00 (0.29%)
Spread: 2.00 (0.018%)
Open: 10,914.00
High: 10,954.00
Low: 10,764.00
Prev. Close: 10,914.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks Slip As Focus Moves To Fed's Yellen

Thu, 25th Aug 2016 16:03

LONDON (Alliance News) - UK equity indices ended lower on Thursday, with pharmaceuticals stocks amongst the biggest blue-chip fallers, as investors look ahead to a speech from US Federal Reserve Chair Janet on Friday at the Jackson Hole conference.

The FTSE 100 closed down 0.3%, or 18.88 points, at 6,816.90. The FTSE 250 ended down 0.7%, or 131.80 points, at 17,882.85, and the AIM All-Share was down 0.3%, or 2.39 points, at 789.67.

The CAC 40 in Paris ended down 0.7% and the DAX 30 in Frankfurt finished down 0.9%.

On Wall Street at the European equity close, the Dow Jones Industrial Average was flat, the S&P 500 was up 0.1% and the Nasdaq Composite was up 0.2%.

Trading volumes have been relatively thin in equity markets in the week so far as investors await Yellen's speech on Friday at 1500 BST. Investors will keep a close eye on her remarks for clues about the outlook for US interest rates, but the Fed Chair is likely to indicate that a US rate hike is still data dependent.

On that front, US durable goods data on Thursday afternoon showed a stronger than expected rise in durable goods orders in July.

The Commerce Department said durable goods orders rose by 4.4% in July after declining by a revised 4.2% in June. Economists had expected orders to climb by about 3.7% compared to the 4.0% slump that had been reported for the previous month.

The bigger-than-expected increase in durable goods orders was partly due to a substantial rebound in orders for transportation equipment, which shot up by 10.5% in July, having fallen by 11.4% in June.

"US durable goods data was really smashing and it has made a lot of difference with respect to what Yellen will say tomorrow," commented Naeem Aslan, chief market analyst at Think Markets. "The data released today has confirmed that we are standing on solid foundations."

At the London stock market close, the pound traded the dollar at USD1.3192, compared to the USD1.3227 seen at the close on Wednesday.

The euro traded the greenback at USD1.1279, largely unchanged from the USD1.1246 at the close on Wednesday.

On the London Stock Exchange, pharmaceutical stocks ended lower after presidential nominee Hillary Clinton raised concerns about the price increase of an allergy product by US pharmaceutical company Mylan.

The price of the company's EpiPen product has risen by 480% since the company acquired it in 2007, moving from USD100 for a 2-pack in 2007 to its current cost of around USD600.

"That's outrageous - and it's just the latest troubling example of a company taking advantage of its consumers," said Clinton in a statement published on her Facebook profile. "It's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."

In response to the growing criticism, Mylan said it would lower the costs of the life-saving treatment for some patients. Mylan said it is taking immediate action to further enhance access to the EpiPen product by expanding already existing programs for patients facing the burden of higher out-of-pocket costs.

Hikma Pharmaceuticals ended as the biggest FTSE 100 faller, down 5.3%, whilst Shire was down 3.0%, AstraZeneca down 1.8%, and GlaxoSmithKline down 0.5%.

CRH ended up 3.4%, the best performer in the FTSE 100, after the Irish building materials company said its profit came in six times higher than a year earlier in its first half, reflecting continued positive momentum in the Americas and the inclusion of acquisitions made in the second half of 2015.

CRH said trading conditions in the first half in Europe reflected the modest impact of early-stage economic recovery.

In the Americas, the company said it expects the positive momentum seen in construction markets during the first half of the year to continue into the second, while in Asia the positive demand backdrop experienced in the Philippines looks set to continue for the rest of the year.

Entertainment One shares sunk after ITV withdrew its proposal to acquire the television and film producer.

ITV made an offer for Entertainment One at 236.00 pence per share, valuing it at around GBP1.03 billion, in early August, but this bid was rebuffed by Entertainment One's board as it said it "fundamentally undervalues" the business.

ITV said Thursday that it has a "clear view of the value" of Entertainment One, and it "appears this value is different to the level at which the board of eOne would currently engage in a more formal process."

The broadcaster said it has a "clear strategy to build a stronger, more diversified international business and will continue its disciplined approach to evaluating its healthy pipeline of potential investment opportunities."

ITV ended down 0.2%, while Entertainment One was the biggest faller in the FTSE 250 index, down 17% to 209.28p.

Infrastructure investor John Laing Group, up 7.4%, said its net asset value rose in the first half of 2016 and maintained its full year guidance for investment commitments.

The company's net asset value per share also rose to 263.00 pence at the end of its first half from 242.00p at the end of December, and 224.00p a year earlier.

"These results demonstrate that our business model is delivering consistent results, and has the ability to cope with today's changing macro-economic environment, including the impact of Brexit," said Chief Executive Olivier Brousse.

The price of gold lost some ground on Thursday, trading at USD1,322.00 an ounce at the London equity market close, versus USD1,327.00 at the same time on Wednesday.

Oil prices, however, moved in the opposite direction, with Brent quoted at USD49.40 a barrel at the close Thursday compared to USD48.75 on Wednesday.

Aside from Yellen's speech on Friday, the focus will be on second quarter GDP readings for the UK at 0930 BST and the US at 1330 BST. Before that is the Japanese consumer price index at 0030 BST, the Gfk consumer confidence survey for Germany at 0700 BST and French GDP at 0745 BST.

At 1330 BST, there are US goods trade balance and personal consumption expenditure prices. The Reuters/Michigan consumer sentiment index is at 1500 BST, and the Baker Hughes US oil rig count is at 1800 BST.

In the UK corporate calendar, casual dining company Restaurant Group, concrete paving manufacturer Marshalls, IT infrastructure company Computacenter, and equipment rental firm Lavendon Group all report interim results.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.